MedPath

河北凯威制药有限责任公司

Ownership
-
Established
2003-12-01
Employees
-
Market Cap
-
Website
www.kivipharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

52

NMPA:52

Drug Approvals

Vitamin A and D Soft Capsules

Product Name
维生素AD软胶囊
Approval Number
国药准字H20074241
Approval Date
Mar 17, 2022
NMPA

Compound Clenbuterol Hydrochloride Soft Capsules

Product Name
复方盐酸克仑特罗软胶囊
Approval Number
国药准字H13023606
Approval Date
Mar 17, 2022
NMPA

Compound Sulfadiazine Granules

Product Name
复方磺胺嘧啶颗粒
Approval Number
国药准字H13023605
Approval Date
Mar 2, 2021
NMPA

Gelibenclamide Tablets

Product Name
格列本脲片
Approval Number
国药准字H13022337
Approval Date
Oct 27, 2020
NMPA

Compound Sulfamethoxazloe Granlues

Product Name
复方磺胺甲噁唑颗粒
Approval Number
国药准字H13023604
Approval Date
Oct 27, 2020
NMPA

Carbamazepine Tablets

Product Name
卡马西平片
Approval Number
国药准字H13022338
Approval Date
Oct 27, 2020
NMPA

Ribavirin Tablets

Product Name
利巴韦林片
Approval Number
国药准字H19993798
Approval Date
Oct 27, 2020
NMPA

Compound Diclofenac Sodium and Chiorphcnamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H13023607
Approval Date
Oct 27, 2020
NMPA

Sulfamethoxazole,Sulfadiazine and Trimethoprim Tablets

Product Name
联磺甲氧苄啶片
Approval Number
国药准字H13022531
Approval Date
Oct 27, 2020
NMPA

Isoniazid Tablets

Product Name
异烟肼片
Approval Number
国药准字H13022547
Approval Date
Oct 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.